CD26/DPP4 as a Therapeutic Target in Nonalcoholic Steatohepatitis Associated Hepatocellular Carcinoma

SIMPLE SUMMARY: CD26/DPP4 has been reported to attenuate anticancer immunity via chemokine cleavage and to promote insulin resistance and inflammation in the liver and/or adipose tissue via dysregulation of macrophage M1/M2 polarization. These results suggest the promotive roles of CD26/DPP4 especia...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishina, Sohji, Hino, Keisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774170/
https://www.ncbi.nlm.nih.gov/pubmed/35053615
http://dx.doi.org/10.3390/cancers14020454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774170/
https://www.ncbi.nlm.nih.gov/pubmed/35053615
http://dx.doi.org/10.3390/cancers14020454

Ejemplares similares